Fluorescence In Situ Hybridization for the Detection of t(X;18)(p11.2;q11.2) in a Synovial Sarcoma Tissue Microarray Using a Breakapart-Style Probe

Synovial sarcomas (SSs) account for 5% of soft tissue tumors and carry a balanced translocation t(X;18)(p11.2;q11.2), detectable in over 90% of cases. This translocation brings together portions of two genes: SYT and SSX. Detecting interruption of the SYT gene on chromosome 18 would be useful as a diagnostic tool. We describe a scoring method to detect disruption of SYT with breakapart probe fluorescence in situ hybridization (FISH) and the application of this method for identification of SS within a sarcoma tissue microarray. After optimization, SYT disruption was identified in 22 of 23 (96%) of known SS tumor samples but was not in 23 of 23 (100%) of non-SS sarcoma samples. Ten of 11 (91%) blinded test SS tumor samples were also correctly identified. For comparison, commercially available FISH and chromogenic in situ hybridization (CISH) probes were tested. The commercial FISH probes identified SYT disruption in 81% of the SS tumor samples but in none of the non-SS samples. The CISH probes produced signals too weak to interpret. The use of breakapart FISH probes is a relatively quick procedure for detection of synovial sarcoma translocations and can be applied to archival specimens in tissue microarrays.

[1]  J. Taubenberger,et al.  Optimization of the Isolation and Amplification of RNA From Formalin-fixed, Paraffin-embedded Tissue: The Armed Forces Institute of Pathology Experience and Literature Review. , 1997, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[2]  K. Nagashima,et al.  Diagnosis of Synovial Sarcoma with the Reverse Transcriptase‐Polymerase Chain Reaction: Analyses of 84 Soft Tissue and Bone Tumors , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[3]  P. Sorensen,et al.  A fluorescence in situ hybridization study of ETV6‐NTRK3 fusion gene in secretory breast carcinoma , 2004, Genes, chromosomes & cancer.

[4]  S. Ansell,et al.  Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. , 1999, The American journal of surgical pathology.

[5]  D. Botstein,et al.  Copyright © American Society for Investigative Pathology Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma with Comparison to Tumors of Similar Histology , 2022 .

[6]  H. Hoekstra,et al.  Chromosomal analysis and the classification of soft tissue sarcomas. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[7]  J. Rossi,et al.  Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  A. G. Kessel,et al.  Molecular mechanisms underlying human synovial sarcoma development. , 2001 .

[9]  M. van de Rijn,et al.  Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. , 1999, American journal of clinical pathology.

[10]  D. Gisselsson,et al.  A novel fusion gene, SS18L1/SSX1, in synovial sarcoma , 2003, Genes, chromosomes & cancer.

[11]  D. Albertson,et al.  Fluorescence in situ hybridization for the detection of DNA and RNA. , 1995, Methods in cell biology.

[12]  E. Haralambieva,et al.  Detection of three common translocation breakpoints in non‐Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin‐embedded tissue sections , 2002, The Journal of pathology.

[13]  M. Werner,et al.  Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies , 1996, Virchows Archiv.

[14]  S. Shim,et al.  Use of FISH to detect chromosomal translocations and deletions. Analysis of chromosome rearrangement in synovial sarcoma cells from paraffin-embedded specimens. , 1993, The American journal of pathology.

[15]  P. Argani,et al.  Performance Characteristics of a Reverse Transcriptase–Polymerase Chain Reaction Assay for the Detection of Tumor-specific Fusion Transcripts from Archival Tissue , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[16]  J. Downing,et al.  Real-time Polymerase Chain Reaction as an Aid for the Detection of SYT-SSX1 and SYT-SSX2 Transcripts in Fresh and Archival Pediatric Synovial Sarcoma Specimens: Report of 25 Cases from St. Jude Children's Research Hospital , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[17]  Kenji Shimizu,et al.  Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. , 2004, Cancer letters.

[18]  A. McMahon,et al.  Identification of poorly differentiated synovial sarcoma: a comparison of clinicopathological and cytogenetic features with those of typical synovial sarcoma , 2003, Histopathology.

[19]  C. Chang,et al.  Molecular genetics of pediatric soft tissue tumors: clinical application. , 2003, The Journal of molecular diagnostics : JMD.

[20]  Robert Maurer,et al.  High‐throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer , 2003, The Journal of pathology.

[21]  J. Davison,et al.  Primary cutaneous Ewing's sarcoma: immunophenotypic and molecular cytogenetic evaluation of five cases. , 1998, The American journal of surgical pathology.

[22]  C. Cooper,et al.  Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. , 1996, The American journal of pathology.

[23]  L. Meisner,et al.  Use of nonbreakpoint DNA probes to detect the t(X;18) in interphase cells from synovial sarcoma: implications for detection of diagnostic tumor translocations. , 1998, The American journal of pathology.

[24]  T. Yamashita,et al.  Detection and Induction of CTLs Specific for SYT-SSX-Derived Peptides in HLA-A24+ Patients with Synovial Sarcoma1 , 2002, The Journal of Immunology.

[25]  Luke Hughes-Davies,et al.  EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer , 2003, Cell.

[26]  G. Sozzi,et al.  Analysis of SYT-SSX Fusion Transcripts and bcl-2 Expression and Phosphorylation Status in Synovial Sarcoma , 2000, Laboratory Investigation.

[27]  B. Bui,et al.  Should molecular testing be required for diagnosing synovial sarcoma? , 2003, Cancer.

[28]  C. Fisher.  Synovial sarcoma. , 1998, Annals of diagnostic pathology.

[29]  R. Gaffney,et al.  Novel fluorescent ligase detection reaction and flow cytometric analysis of SYT-SSX fusions in synovial sarcoma. , 2003, The Journal of molecular diagnostics : JMD.

[30]  J. Taubenberger,et al.  Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction. , 2002, The Journal of molecular diagnostics : JMD.

[31]  D. Smedley,et al.  Dual colour fluorescence in situ hybridization to paraffin‐embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma , 1999, The Journal of pathology.

[32]  M. Rijn,et al.  Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. , 1999 .

[33]  F. Clayton,et al.  Novel application of a fibrin cell block method to evaluate melanocytic cell populations. , 2003, Pigment cell research.

[34]  M. Ladanyi,et al.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. , 1994, The American journal of pathology.

[35]  C. Caldas,et al.  A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples , 2003, Molecular pathology : MP.

[36]  J. Fletcher,et al.  Detection of chromosome 18 rearrangement in synovial sarcoma by fluorescence in situ hybridization. , 1995, Cancer genetics and cytogenetics.

[37]  M. O'sullivan,et al.  Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? , 2000, Histopathology.

[38]  N. Sneige,et al.  The Use of TMA for Interlaboratory Validation of FISH Testing for Detection of HER2 Gene Amplification in Breast Cancer , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  A. V. van Kessel,et al.  Molecular mechanisms underlying human synovial sarcoma development , 2001, Genes, chromosomes & cancer.

[40]  M. Ladanyi,et al.  Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[41]  M. Rocchi,et al.  A novel FISH assay for SS18–SSX fusion type in synovial sarcoma , 2004, Laboratory Investigation.